Synthetic Biology Market, By Product (Oligonucleotides , Enzymes , Synthetic Cells , Chassis Organism , and Others), By Technology (Genome Engineering , PCR Technology , Bioprocessing Technology , NGS Technology , Bioinformatics , Nanotechnology , and Oth

Synthetic Biology Market, By Product (Oligonucleotides , Enzymes , Synthetic Cells , Chassis Organism , and Others), By Technology (Genome Engineering , PCR Technology , Bioprocessing Technology , NGS Technology , Bioinformatics , Nanotechnology , and Others), By End User (Pharmaceutical Companies , Biotechnology Companies , CMO & CRO , and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Synthetic biology is an emerging field that applies engineering principles to biology. It involves the design and construction of novel artificial biological pathways, organisms or devices or the re-design of existing natural biological systems. Some key applications of synthetic biology include development of advanced biomanufacturing techniques for fuels, chemicals and materials as well as development of engineered organisms for agriculture, pharmaceuticals and environmental solutions. Researchers are working towards developing engineered biological systems for more effective and environment-friendly production processes. Advancements in DNA sequencing, gene assembly, and editing techniques have enabled rapid progress in the field with the potential to address many pressing global challenges in healthcare, energy, and environment.

Market Dynamics:

The global synthetic biology market is driven by factors such as increasing R&D funding and investment in the field, advancements in DNA sequencing and gene editing technologies, rising demand for biopharmaceuticals, and development of techniques like metabolic engineering. Industry standards are being developed to ensure the responsible and safe application of synthetic biology. However, regulatory issues relating to genetically engineered organisms and ethical concerns could potentially restrain the market growth. Synthetic biology offers opportunities to address challenges in several sectors like drug discovery, industrial biomanufacturing, and environmental remediation. Development of commercial applications, international collaborations, and improved cost efficiencies in DNA synthesis and genome engineering will support market expansion.

Key Features of the Study:

• This report provides an in-depth analysis of the global synthetic biology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global synthetic biology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Thermo Fisher Scientific, Synbio Technologies, Merck KGaA, Agilent Technologies Inc., GenScript, Amyris, Eurofins Genomics GmbH, Integrated DNA Technologies Inc., Codexis Inc., EnBiotix Inc., Synthego, New England Biolabs (UK) Ltd., Scarab Genomics LLC , Genomatica Inc., Novonesis Group, Bota Bio, Creative Biogene, and Illumina, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global synthetic biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global synthetic biology market.

Market Segmentation

• Product:
• Oligonucleotides
• Enzymes
• Synthetic Cells
• Chassis Organism
• Others
• Technology:
• Genome Engineering
• PCR Technology
• Bioprocessing Technology
• NGS Technology
• Bioinformatics
• Nanotechnology
• Others
• End User:
• Pharmaceutical Companies
• Biotechnology Companies
• CMO & CRO
• Others
• Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Company Profiles:
• Thermo Fisher Scientific
• Synbio Technologies
• Merck KGaA
• Agilent Technologies Inc.
• GenScript
• Amyris
• Eurofins Genomics GmbH
• Integrated DNA Technologies Inc.
• Codexis Inc.
• EnBiotix Inc.
• Synthego
• New England Biolabs (UK) Ltd.
• Scarab Genomics LLC
• Genomatica Inc.
• Novonesis Group
• Bota Bio
• Creative Biogene
• Illumina, Inc.